Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the use of pramipexole dihydrochloride and quetiapine
(Seroquel) XR as combination therapy for bipolar depression. The proposed benefit of the
combination therapy investigated in this study is improved treatment of bipolar depression.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.